SciTech Development: Communication and Outreach During Clinical Trials
SciTech Development, a biotech company running clinical trials, had low public awareness and fragmented messaging across channels. Gadsly managed their press releases, LinkedIn and Twitter, and segmented newsletters for investors, partners and industry professionals. Results included features in industry publications, 50% follower growth in six months and a 35% average newsletter open rate.
- follower growth on LinkedIn and Twitter in six months
- 50%
- average newsletter open rate
- 35%
- Client
- SciTech Development
- Industry
- Biotech / Healthcare
- Services
- Social Media, Marketing Consulting
- Live site
- scitechsdp.com
SciTech Development is a biotechnology company developing new therapies. As they began critical clinical trials, they brought in Gadsly to manage press releases, social media and newsletters. The goal: communicate progress clearly, keep stakeholders engaged and build trust in the industry during a pivotal phase.
The challenge
- Limited public awareness: promising therapies, but their progress wasn't widely recognized.
- Fragmented messaging: channels lacked consistency and a single brand voice.
- Diverse audiences: investors, researchers, regulators and potential collaborators all needed to be reached, each in a different way.
What we did
Press releases
We wrote press releases announcing SciTech's milestones and trial updates:
- Strategic storytelling that explained the significance and potential impact of the trials.
- Broad distribution through media contacts and platforms to reach industry stakeholders.
- Timing matched to key trial phases to keep momentum and interest.
Social media management
We built a social media program for the trial phase:
- Platform focus: LinkedIn and Twitter, to reach professionals, industry leaders and regulatory audiences.
- Content: trial progress, key achievements and industry insights.
- Engagement: active conversations with followers and in wider discussions about clinical research.
Newsletters
We designed and sent newsletters to keep SciTech's audiences informed:
- Segmentation: separate versions for investors, partners and industry professionals.
- Content: trial updates, research progress, upcoming events and regulatory milestones.
- Calls to action: visit the website, download resources or contact the team.
The results
Press
- Increased media coverage, including features in prominent industry publications.
- Wider recognition of SciTech's research and its potential impact.
Social media
- 50% follower growth on LinkedIn and Twitter within six months.
- Strong engagement on trial-related posts.
- Visibility with key stakeholders, including investors and regulators.
Newsletters
- 35% average open rate, above industry benchmarks.
- Stronger stakeholder relationships through timely, useful updates.
Consistent, well-timed communication helped SciTech stay transparent and build trust during a critical period. If you need help shaping the message itself, that's where marketing consulting comes in.
Facing a high-stakes moment? Book a free call.